Over the past several years, significant progress has been made in understanding of the etiology and pathogenesis of periodontal diseases. Nevertheless, the nature and contribution of the immune system to these disorders remain unclear. The application presents the hypothesis that the immune system plays a primary role to minimize and/or prevent infection. Furthermore, the application posits that immunoregulatory abnormalities contribute to the pathogenesis of and susceptibility to periodontal disease. In this regard, the preliminary investigations have demonstrated that several periodontal pathogens produce factors capable of impairing human T- and B-cell function; these include Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum and Treponema denticola. The fundamental hypothesis of the planned studies is that periodontal pathogens produce immunosuppressive proteins (ISPS) that mediate local and/or systemic immunosuppression, thereby enhancing their own virulence and/or that of other opportunistic microorganisms. The current plan is to focus this investigation on the A. actinomycetemcomitans ISP, recently shown to induce human lymphocytes to irreversibly arrest in the G2 phase of the cell cycle. Moreover, the applicants have determined that this ISP is the product of the cdtB gene, one of three genes encoding the family of cytolethal distending toxins. The objectives of this application are to define the cascade of events responsible for CdtB-induced G2 arrest and to determine the relationship between structure and function of this ISP. The study is composed of four Specific Aims: 1) to determine the underlying molecular mechanism(s) responsible for the failure of CdtB-treated T-cells to de-phosphorylate and, thereby activate, the cyclin dependent kinase (cdk), cdkl; 2) to determine if a receptor is involved in the binding of CdtB and/or the holo-Cdt toxin to the surface of T-cells; 3) to determine if CdtB is part of a hetero-oligomer that forms a holo-Cdt toxin; and 4) to determine if conserved motifs that exist in all known CdtB polypeptides represent functional domains of the protein.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE006014-22
Application #
6706880
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Lunsford, Dwayne
Project Start
1982-08-01
Project End
2006-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
22
Fiscal Year
2004
Total Cost
$331,661
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Dentistry
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Boesze-Battaglia, Kathleen; Walker, Lisa P; Dhingra, Anuradha et al. (2017) Internalization of the Active Subunit of the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Is Dependent upon Cellugyrin (Synaptogyrin 2), a Host Cell Non-Neuronal Paralog of the Synaptic Vesicle Protein, Synaptogyrin 1. Front Cell Infect Microbiol 7:469
Leonard, Stephanie A; Petito, Lucia C; Stephansson, Olof et al. (2017) Weight gain during pregnancy and the black-white disparity in preterm birth. Ann Epidemiol 27:323-328.e1
Shenker, Bruce J; Boesze-Battaglia, Kathleen; Scuron, Monika Damek et al. (2016) The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Cell Microbiol 18:223-43
Scuron, Monika D; Boesze-Battaglia, Kathleen; Dlaki?, Mensur et al. (2016) The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin. Front Cell Infect Microbiol 6:168
Shenker, B J; Walker, L P; Zekavat, A et al. (2016) Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate. Mol Oral Microbiol 31:33-42
Boesze-Battaglia, Kathleen; Walker, Lisa P; Zekavat, Ali et al. (2015) The Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Active Subunit CdtB Contains a Cholesterol Recognition Sequence Required for Toxin Binding and Subunit Internalization. Infect Immun 83:4042-55
Shenker, Bruce J; Ojcius, David M; Walker, Lisa P et al. (2015) Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infect Immun 83:1487-96
Shenker, Bruce J; Walker, Lisa P; Zekavat, Ali et al. (2014) Blockade of the PI-3K signalling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines. Cell Microbiol 16:1391-404
Shenker, Bruce J; Ali, Hydar; Boesze-Battaglia, Kathleen (2011) PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases. Curr Pharm Des 17:3815-22
Shenker, Bruce J; Boesze-Battaglia, Kathleen; Zekavat, Ali et al. (2010) Inhibition of mast cell degranulation by a chimeric toxin containing a novel phosphatidylinositol-3,4,5-triphosphate phosphatase. Mol Immunol 48:203-10